Structure-activity relationship of carbacephalosporins and cephalosporins: Antibacterial activity and interaction with the intestinal proton-dependent dipeptide transport carrier of caco-2 cells

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 8, 1997, Pages 1649-1657

  Snyder, Nancy J ^a   Tabas, Linda B ^a   Berry, Donnis M ^a   Duckworth, Dale C ^a   Spry, Douglas O ^a   Dantzig, Anne H ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBACEPHEM DERIVATIVE; CARRIER PROTEIN; CEFALEXIN; CEFAMANDOLE; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CYCLACILLIN; LORACARBEF; PHENYLGLYCINE;

ANTIBACTERIAL ACTIVITY; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG HYDROLYSIS; DRUG UPTAKE; ENTEROCOCCUS FAECALIS; HAEMOPHILUS INFLUENZAE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTESTINE CELL; LIPOPHILICITY; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STEREOISOMERISM; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; STRUCTURE ACTIVITY RELATION;

EID: 0030877222     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.8.1649     Document Type: Article

References (49)

1. Achiwa, K., S. Terashima, H. Mizuno, N. Takamura, T. Kitagawa, K. Ishikawa, and S.-I. Yamada. 1970. Studies on optically active amino acids. XVIII. Studies on α-methyl-α-amino acids. XIV. Several optical properties of α-methyl-α-amino acids. Chem. Pharm. Bull. 18:61-74.
2. Alburn, H. E., D. E. Clark, H. I. Fletcher, and N. H. Grant. 1967. Synthesis of new broad-spectrum aminoalicyclic penicillins, p. 586-589. Antimicrob. Agents Chemother. 1966.
3. Amidon, G. L., and H. J. Lee. 1994. Absorption of peptide and peptidomimetic drugs. Annu. Rev. Pharmacol. Toxicol. 34:321-341.
4. Bai, P., P. Subramanian, H. I. Mosberg, and G. L. Amidon. 1991. Structural requirements for the intestinal mucosal-cell peptide transporter: the need for N-terminal α-amino group. Pharm. Res. 8:593-599.
5. Barton, D. H. R., N. Y. Bhatnagar, J. Blazejewski, B. Chariot, J. Finet, D. J. Lester, W. B. Motherwell, M. T. B. Papoula, and S. P. Stanforth. 1985. Pentavalent organobismuth reagents. Part 2. The phenylation of phenols. J. Chem Soc. Perkin Trans. 1:2657-2665.
6. Barton, D. H. R., N. Y. Bhatnagar, J. Finet, and W. B. Motherwell. 1986. Pentavalent organobismuth reagents. Part VI. Comparative migratory aptitudes of aryl groups in the arylation of phenols and enols by pentavalent bismuth reagents. Tetrahedron 42:3111-3122.
7. Barton, D. H. R., J. Finet, and J. Khamsi. 1989. N-phenylation of amino acid derivatives. Tetrahedron Lett. 30:937-940.
8. Berteloot, A., A. H. Khan, and K. Ramaswamy. 1981. Characteristics of dipeptide transport in normal and papain-treated brush border membrane vesicles from mouse intestine. II. Uptake of glycyl-L-leucine. Biochim. Biophys. Acta 649:179-188.
9. Black, H. R., K. A. DeSante, J. D. Wolny, and G. L. Brier. 1988. Pharmacology and pharmacokinetics of single oral doses of LY163892, abstr. 123, p. 132. In Program and abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society of Microbiology, Washington, D.C.
10. Brown, R. F., M. D. Kinnick, J. M. Morin, R. T. Vasileff, F. T. Counter, E. O. Davidson, P. W. Ensminger, J. A. Eudaly, J. S. Kasher, A. S. Katner, R. E. Koehler, K. D. Kurz, T. D. Lindstrom, W. H. W. Lunn, D. A. Preston, J. L. Ott, J. F. Quay, J. K. Shadle, M. I. Steinberg, J. F. Stucky, J. K. Swartzendruber, J. R. Turner, J. A. Webber, W. E. Wright, and K. M. Zimmerman. 1990. Synthesis and biological evaluation of a series of parenteral 3′-quaternary ammonium cephalosporins. J. Med. Chem. 33:2114-2121.
11. Catnach, S. M., P. D. Fairclough, and S. M. Hammond. 1994. Intestinal absorption of peptide drugs: advances in our understanding and clinical implications. Gut 35:441-444.
12. Daniel, H., and D. T. Thwaites. 1995. Stereoselective uptake of β-lactam antibiotics by the intestinal peptide transporter. Br. J. Pharm. 116:3021-3027.
13. Dantzig, A. H., and L. Bergin. 1990. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim. Biophys. Acta 1027:211-217.
14. Dantzig, A. H., D. C. Duckworth, and L. B. Tabas. 1994. Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells. Biochim. Biophys. Acta 1191:7-13.
15. Dantzig, A. H., L. B. Tabas, and L. Bergin. 1992. Cefaclor uptake by the proton-dependent dipeptide transport carrier of human intestinal Caco-2 cells and comparison to cephalexin uptake. Biochim. Biophys. Acta 1112: 167-173.
16. DeSante, K. A., and M. L. Zeckel. 1992. Pharmacokinetic profile of loracarbef. Am. J. Med. 92(Suppl. 6A):16S-19S.
17. Ganapathy, V., G. Burckhardt, and F. H. Leibach. 1985. Peptide transport in rabbit intestinal brush-border membrane vesicles studies with a potential-sensitive dye. Biochim. Biophys. Acta 816:234-240.
18. Ganapathy, V., and F. H. Leibach. 1983. Role of pH gradient and membrane potential in dipeptide transport in intestinal and renal brush-border membrane vesicles from the rabbit. Studies with L-carnosine and glycyl-L-proline. J. Biol. Chem. 258:14189-14192.
19. Ganapathy, V., J. R. Mendicino, and F. H. Leibach. 1981. Transport of glycyl-L-proline into intestinal and renal brush border vesicles from rabbit. J. Biol. Chem. 256:116-124.
20. Gazzola, G. C., V. Dall'Asta, R. Franchi-Gazzola, and M. F. White. 1981. The cluster tray method for rapid measurement of solute fluxes in adherent cultured cells. Anal. Biochem. 115:368-374.
21. Hansch, C., J. P. Bjorkroth, and A. Leo. 1987. Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. J. Pharm. Sci. 79:663-687.
22. Hidalgo, J., and J. Li. 1996. Molecular modeling study of structural requirements for the oligopeptide transporter. J. Drug Targeting 4:9-17.
23. Hutt, A. J., and J. O'Grady. 1996. Drug chirality: a consideration of the significance of the stereochemistry of antimicrobial agents. J. Antimicrob. Chemother. 37:7-32.
24. Kaminski, Z. J. 1985. 2-Chloro-4,6-disubstituted-1,3,5-triazines - a novel group of condensing reagents. Tetrahedron Lett. 26:2901-2904.
25. Kasher, J. S., J. A. Eudaly, R. Johnson, and J. Shoufler. 1988. Pharmacokinetics of orally absorbed beta-lactam antibiotics LY228238 and LY257128 in laboratory animals, abstr. 535, p. 202. In Program and abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
26. Krishnamurthy, S. 1982. A highly efficient and general N-monomethylation of functionalized primary amines via formylation - borane:methyl sulfide reduction. Tetrahedron Lett. 23:3315-3318.
27. Luthy, R., R. Munch, J. Blaser, H. Bhend, and W. Siegenthaler. 1979. Human pharmacology of cefotaxime (HR 756), a new cephalosporin. Antimicrob. Agents Chemother. 16:127-133.
28. Matthews, D. M., and J. W. Payne. 1980. Transmembrane transport of small peptides. Curr. Top. Membr. Transp. 14:331-425.
29. Meyers, B. R., B. Ribner, S. Yancovitz, and S. Z. Hirschman. 1976. Pharmacological studies with cefamandole in human volunteers. Antimicrob. Agents Chemother. 9:140-144.
30. Oh, D., P. J. Sinko, and G. L. Amidon. 1993. Characterization of the oral absorption of some β-lactams: effect of the α-amino side chain group. J. Pharm. Sci. 82:897-900.
31. Quay, J. F., D. L. Coleman, L. S. Finch, J. M. Indelicato, C. E. Pasini, J. R. Shoufler, H. R. Sullivan, and J. C. Turner. 1987. Pharmacokinetics of orally absorbed β-lactam antibiotics LY163892 (KT3777) and LY213735 (KT3799) in laboratory animals, abstr. 1205, p. 307. In Program and abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
32. Rajendran, V., J. M. Harig, and K. Ramaswamy. 1987. Characteristics of glycyl-L-proline transport in intestinal brush-border membrane vesicles. Am. J. Physiol. 252(Gastrointest. Liver Physiol. 15):G281-G286.
33. Rajendran, V. M., A. Berteloot, and K. Ramaswamy. 1985. Transport of glycyl-L-proline by mouse intestinal brush-border membrane vesicles. Am. J. Physiol. 248:G682-G686.
34. Said, H. M., F. K. Ghishan, and R. Redha. 1988. Transport of glycyl-L-proline in intestinal brush-border membrane vesicles of the suckling rat: characteristics and maturation. Biochim. Biophys. Acta 941:232-240.
35. Sakane, K., Y. Inamoto, and T. Takaya. 1992. A new oral cephem, cefdinir: its structure-activity relationships and biological profile. Jpn. J. Antibiot. 45:909-925.
36. Sezaki, H., and T. Kimura. 1983. Carrier-mediated transport in drug absorption, p. 133-142. In D. D. Breimer and P. Speiser (ed.), Topics in pharmaceutical sciences. Elsevier Science Publishers B.V., Amsterdam, The Netherlands.
37. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Garter, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.
38. Snyder, N. J., A. H. Dantzig, D. O. Spry, and L. B. Tabas. 1991. Effect of β-lactam antibiotics on cephalexin transport via the proton dependent transport carrier of human intestinal Caco-2 cells. Part II. New synthesis and antibacterial activity, abstr. 165, p. 126. In Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
39. Snyder, N. J., L. B. Tabas, D. M. Berry, D. C. Duckworth, D. O. Spry, and A. H. Dantzig. 1993. Structure-activity relationship of loracarbef: antibacterial activity and interaction with the intestinal proton-dependent dipeptide transport carrier of Caco-2 cells, p. 132-133. In J. Einhorn (ed.), Recent advances in chemotherapy. American Society for Microbiology, Washington, D.C.
40. Snyder, N. J., L. B. Tabas, D. M. Berry, D. O. Spry, and A. H. Dantzig. 1992. Uptake of β-lactam antibiotics into human intestinal Caco-2 cells via the proton-dependent dipeptide transport carrier, abstr. 1461, p. 354. In Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
41. Sonntag, N. O. V. 1953. The reactions of aliphatic acid chlorides. Chem. Rev. 52:237-416.
42. Spry, D. O., J. S. Kasher, and N. J. Snyder. 1989. C(3)-cyclopropyl cephems and carbacephems. J. Antibiot. 42:1653-1660.
43. Tabas, L. B., L. Bergin, and A. H. Dantzig. 1991. Effect of β-lactam antibiotics on cephalexin transport via the proton-dependent dipeptide transport carrier of human intestinal Caco-2 cells. Part 1. Clinically used β-lactams, abstr. 164, p. 126. In Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
44. Tamai, I., H.-Y. Ling, S.-M. Timbul, J. Nishikido, and A. Tsuji. 1988. Stereospecific absorption and degradation of cephalexin. J. Pharm. Pharmacol. 40:320-324.
45. Tamura, K., P. K. Bhatnagar, J. S. Takata, C.-P. Lee, P. L. Smith, and R. T. Borchardt. 1996. Metabolism, uptake, and transepithelial transport of the diastereomers of Val-Val in the human intestinal cell line, Caco-2. Pharm. Res. 13:1213-1218.
46. Tamura, K., C.-P. Lee, P. L. Smith, and R. T. Borchardt. 1996. Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2. Pharm. Res. 13:1663-1667.
47. Washington, J. A., and V. L. Sutter. 1980. Dilution susceptibility test: agar and macro-broth dilution procedure, p. 453-458. In E. H. Lennette, A. Balows, W. J. Hausler, Jr., and J. P. Truant (ed.), Manual of clinical microbiology, 3rd ed. American Society for Microbiology, Washington, D.C.
48. Wilson, D., J. A. Barry, and K. Ramaswamy. 1989. Characteristics of tripeptide transport in human jejunal brush-border membrane vesicles. Biochim. Biophys. Acta 986:123-129.
49. Yoshikawa, T., N. Muranashi, M. Yoshida, T. Oguma, K. Hirano, and H. Yamada. 1989. Transport characteristics of ceftibuten, a new oral cephem, in rat intestinal BBMV: proton coupled and stereospecific transport of ceftibuten. Pharm. Res. 6:302-307.